EcoDrugPlus

Tubulin Beta Chain-Like

Ensembl ID : ENSPLAG00000000569
Gene Symbol: LOC106958824
3 Cross references
305 Possible Orthologues:

Tubulin Beta-4b Chain-Like

Ensembl ID : ENSPLAG00000011901
Gene Symbol: LOC106954318
2 Cross references
12 Possible Orthologues:

Tubulin Beta-4b Chain-Like

Ensembl ID : ENSPLAG00000002746
Gene Symbol: LOC106953252
2 Cross references
12 Possible Orthologues:

Tumor Protein P53

Ensembl ID : ENSPLAG00000007454
Gene Symbol: TP53
2 Cross references
232 Possible Orthologues:

Tyrosinase

Ensembl ID : ENSPLAG00000017748
Gene Symbol: TYR
3 Cross references
202 Possible Orthologues:

Tyrosinase

Ensembl ID : ENSPLAG00000001788
Gene Symbol: TYR
4 Cross references
198 Possible Orthologues:

Tyrosine Hydroxylase

Ensembl ID : ENSPLAG00000003125
Gene Symbol: TH
3 Cross references
187 Possible Orthologues:

Tyrosine Kinase 2

Ensembl ID : ENSPLAG00000021239
Gene Symbol: TYK2
3 Cross references
195 Possible Orthologues:

Tyrosine Kinase With Immunoglobulin Like And Egf Like Domains 1

Ensembl ID : ENSPLAG00000001430
Gene Symbol: TIE1
3 Cross references
205 Possible Orthologues:

Tyrosine-Protein Kinase Jak2-Like

Ensembl ID : ENSPLAG00000005705
Gene Symbol: LOC106946415
3 Cross references
199 Possible Orthologues:

Tyrosine-Protein Kinase Lyn-Like

Ensembl ID : ENSPLAG00000012845
Gene Symbol: LOC106961740
3 Cross references
195 Possible Orthologues:

Tyrosine-Protein Kinase Yes

Ensembl ID : ENSPLAG00000006200
Gene Symbol: LOC106954461
3 Cross references
206 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).